Mel C. Schroeder

"Diversomers": an approach to nonpeptide, nonoligomeric chemical diversity.

Sheila H. DeWitt, John S. Kiely, Charles J. Stankovic et al. · Proceedings of the National Academy of Sciences · 1993 · 339 citations

Pharmacy, Chemistry, Medicinal Chemistry +14

Structure−Activity Relationships for a Novel Series of Pyrido[2,3-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors

James M. Hamby, Cleo J. C. Connolly, Mel C. Schroeder et al. · Journal of Medicinal Chemistry · 1997 · 142 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Anti-Angiogenic Activity of Selected Receptor Tyrosine Kinase Inhibitors, PD166285 and PD173074: Implications for Combination Treatment with Photodynamic Therapy

Charles J. Dimitroff, Wayne D. Klohs, Amarnath Sharma et al. · Investigational New Drugs · 1999 · 96 citations

Medicine, Oncology, Pharmacology +13

Discovery and structure-activity studies of a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors

Cleo J. C. Connolly, James M. Hamby, Mel C. Schroeder et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 66 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.

Thomas F. Woolf, W F Pool, Susan M. Bjorge et al. · Drug Metabolism and Disposition · 1993 · 62 citations

Medicine, Biochemistry, Pharmacology +17